Predictors of Exercise-induced Oxygen Desaturation in Systemic Sclerosis Patients with Interstitial Lung Disease
Overview
Affiliations
Background: The diffusion capacity of the lung for carbon monoxide (DLCO) is a good marker of disease severity in patients with idiopathic interstitial pneumonia, and is associated with oxygen saturation; however, little is known about DLCO in systemic sclerosis patients with interstitial lung disease. We studied potential predictors of exercise-induced oxygen desaturation in patients with systemic sclerosis.
Methods: Data were collected prospectively from 80 of 110 consecutive systemic sclerosis patients with normal oxygen saturation (> 95%) at rest, who could perform the 6-min walk test without physical discomfort, including leg pain. Pulmonary function tests and echocardiography were collected from all subjects.
Results: Thirty subjects showed a ≥ 4% decline in oxygen saturation during the 6-min walk test (desaturation group). The other subjects were assigned to the normoxic group. The percent-of-predicted values for FVC, FEV1, total lung capacity, DLCO, and DLCO/alveolar volume were lower, and FEV1/FVC was higher, in the desaturation group. Logistic regression analysis showed the percent-of-predicted DLCO as a highly accurate predictor of exercise-induced oxygen desaturation: the area under the receiver operating characteristic curve was 0.92 (cutoff point 56.3%, sensitivity 0.83, specificity 0.86). Five subjects over the cutoff point of the percent-of-predicted DLCO in the desaturation group could not be distinguished from the normoxic subjects with the lung-volume measurements or right-ventricular systolic pressure.
Conclusions: The factor underlying exercise-induced oxygen desaturation appeared to be reduced percent-of-predicted DLCO, which was useful as a predictor in over 80% of the subjects.
Matsuoka Y, Horio T, Ono M, Yoshimura R, Fukuda K, Shimizu M Heart Vessels. 2024; 39(10):877-883.
PMID: 38734834 DOI: 10.1007/s00380-024-02411-8.
Kim S, Shin Y, Shin M, Hong C, Huh S, Yoo W Ther Adv Respir Dis. 2023; 17:17534666231186732.
PMID: 37462163 PMC: 10357056. DOI: 10.1177/17534666231186732.
Clinical significance and usefulness of rehabilitation for systemic sclerosis.
Mugii N, Hamaguchi Y, Maddali-Bongi S J Scleroderma Relat Disord. 2022; 3(1):71-80.
PMID: 35382125 PMC: 8892873. DOI: 10.1177/2397198317750043.
The effect and safety of exercise therapy in patients with systemic sclerosis: a systematic review.
Liem S, Vliet Vlieland T, Schoones J, de Vries-Bouwstra J Rheumatol Adv Pract. 2019; 3(2):rkz044.
PMID: 31858074 PMC: 6913710. DOI: 10.1093/rap/rkz044.